4th Sep 2014 13:31
LONDON (Alliance News) - European biopharmaceutical company Biofrontera AG PLC Thursday said Chief Financial Officer Thomas Schaffer bought 2,000 shares at a price of EUR2.320 per share.
Following this transaction, Schaffer has a beneficial interest in 10,088 shares, representing 0.045% of the issued share capital.
Shares were down 0.9% at EUR2.30 Thursday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
B8F.L